SHARE

Merck forecasts flat full-year sales following halt in shipments to China

The pharmaceutical group forecast full-year sales of $64.1bn to $65.6bn in 2025, broadly flat compared to $64.1bn of sales last year. Merck decided to pause shipments of vaccine, Gardasil, to China until at least mid-year which has impacted forecasts.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.